Life Science Tools and Reagents: Global Markets

Report Highlights

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

Report Includes

• 85 data tables and 44 additional tables
• An analysis of the global markets for life science tools and reagents, including COVID-19 diagnostics products
• Analyses of the global market trends, with market revenue data (sales figures) from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
• An estimate of the market size and revenue forecast for the market for life science tools and diagnostics, and a corresponding market share analysis based on product type, application and region
• Highlights of the current and future market potential of life science tools and diagnostics, along with an analysis of the competitive landscape, regulatory scenario and technological advances
• Facts and figures pertaining to the market dynamics, opportunities and deterrents, emerging technologies, future prospects and the impacts of macroeconomic variables
• An assessment of current products and identification of new potential markets for novel products and assay development
• A discussion on how scientific trends, government policies and the economy in general affect this market, as well as how the life science tools and diagnostics industry differs from the pharmaceutical and drug discovery industry
• A discussion of sustainability trends in the market, with emphasis on consumer attitudes, an analysis of companies’ ESG scores, the future of ESG, case studies, and the ESG practices of leading companies
• An analysis of the key patent grants and recently published patents
• Identification of the major vendors along with an analysis of the competitive landscape, including company market shares, recent M&A activity and the outlook for venture funding
• Profiles of the leading market players, including Thermo Fisher Scientific, Danaher Corp., Merck KGaA, Roche and Qiagen

Report Scope

This report provides an analysis of the market for life sciences tools and reagents, including the leading companies, their revenues, product portfolios and recent activities. It looks at the competitive landscape and market dynamics such as drivers, restraints and opportunities. It sizes of the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, protein reagents and probes. The life science instruments include hybridization systems, PCR, Western blotting instruments, and ELISA instruments. The regions whose markets are analyzed are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Markets are also analyzed by application.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Christian Goodwin, MD, MPH, is a resident physician at Duke University. He completed his undergraduate degree at the University of Virginia. He obtained his MPH at the University of Liverpool as a US-UK Fulbright Scholar while serving as a visiting researcher at the Palliative Care Institute Liverpool. He obtained his MD from the University of North Carolina as a Blanchard Scholar. Christian has expertise in health systems innovation, public health research, geriatrics, and psychiatry.